Niagen Bioscience Stock

Niagen Bioscience OCF Margin

The Operating Cash Flow Margin of Niagen Bioscience (NAGE) as of Aug 14, 2026 is 10.38 %. In the previous year, Operating Cash Flow Margin was 12.16 % — a change of -14.61% (lower).

OCF Margin

10.38 %

YoY

-14.61%

Last updated:

Operating Cash Flow Margin of Niagen Bioscience is 2026 10.38 % . Operating Cash Flow Margin of Niagen Bioscience was 2025 12.16 % . It decreases by -14.61% lower compared to the previous year.
Access this data via the Eulerpool API

Niagen Bioscience Stock analysis

What does Niagen Bioscience do? The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Niagen Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Niagen Bioscience stock

Operating Cash Flow Margin of Niagen Bioscience is 10.38 % in 2026.

Operating Cash Flow Margin of Niagen Bioscience changed from 12.16 % to 10.38 %, representing a -14.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Niagen Bioscience since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Niagen Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Niagen Bioscience

All Key Metrics — Niagen Bioscience